Methods and compositions for modulating conditions in both mammals and plants
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-038/07
A61K-038/08
C07K-005/00
C07K-007/00
출원번호
UP-0287157
(2005-11-25)
등록번호
US-7704955
(2010-05-20)
발명자
/ 주소
Skubatch, Hanna
출원인 / 주소
Neopro Pain, Inc.
대리인 / 주소
Wilson Sonsini Goodrich & Rosati
인용정보
피인용 횟수 :
3인용 특허 :
12
초록▼
The invention relates to compositions comprising of SEQ NO: 1-244, 248-249, and any homologs, analogs, and fragments thereof. Such compositions can be used to treat, prevent, and modulate pain, inflammation, and metabolic processes in various organisms including plants and animals. Such compositions
The invention relates to compositions comprising of SEQ NO: 1-244, 248-249, and any homologs, analogs, and fragments thereof. Such compositions can be used to treat, prevent, and modulate pain, inflammation, and metabolic processes in various organisms including plants and animals. Such compositions can be formulated with an acceptable pharmaceutical excipient for administration to a human or a plant. The compositions can be administered topically or for systemic use.
대표청구항▼
The invention claimed is: 1. A composition comprising an isolated polypeptide consisting of SEQ ID NO: 1. 2. A composition comprising an isolated polypeptide consisting of FLPSXa (SEQ ID NO: 261) wherein a ≦2 and X is any amino acid. 3. A composition comprising an isolated polypeptide co
The invention claimed is: 1. A composition comprising an isolated polypeptide consisting of SEQ ID NO: 1. 2. A composition comprising an isolated polypeptide consisting of FLPSXa (SEQ ID NO: 261) wherein a ≦2 and X is any amino acid. 3. A composition comprising an isolated polypeptide consisting of FLPSXa (SEQ ID NO: 261) wherein a ≦4 and X is any L or D amino acid. 4. A composition comprising an isolated polypeptide consisting of FLPSXa (SEQ ID NO: 261) wherein a ≦4 and X is any alpha amino acid. 5. A composition comprising an isolated polypeptide consisting of XbFLPSXa (SEQ ID NO: 263), wherein (a+b) ≦4; wherein when a=1, then b≠1 and wherein b=1, then a≠1; wherein when b=2, then a≠0; wherein when a=0, then b≠2; and wherein Xb, and Xa are any L- or D-amino acid. 6. A composition comprising an isolated polypeptide consisting of XbFLPSXa (SEQ ID NO: 263), wherein (a+b) ≦4; wherein when a=1, then b≠1 and wherein b=1, then a≠1; wherein when b=2, then a≠0; wherein when a=0, then b≠2; wherein Xb=0 then Xa≠3; and wherein Xb and Xa are any amino acid. 7. A composition comprising an isolated polypeptide consisting of XbFLPSXa (SEQ ID NO: 263), wherein (a+b) ≦4; wherein when a=1, then b≠1 and wherein b=1, then a≠1; wherein when b=2, then a≠0; wherein when a=0, then b≠2; wherein Xb and Xa are any alpha amino acid. 8. The composition of any one of claims 1, 2, 3-6 or 7 wherein said composition further comprises a phannaceutical excipient. 9. The composition of any one of claims 1, 2, 3-6 or 7 wherein said composition further comprises a penetration enhancing agent. 10. The composition of any one of claims 1, 2, 3-6 or 7 wherein said composition is formulated for oral delivery. 11. The composition of any one of claims 1, 2, 3-6 or 7 wherein said composition is formulated for topical delivery. 12. The composition of any one of claims 1, 2, 3-6 or 7 wherein said composition is formulated for parenteral delivery. 13. The composition of any one of claims 1, 2, 3-6 or 7 wherein said composition is an aerosol.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (12)
Maria A. Vitiello ; Robert W. Chestnut ; Alessandro D. Sette ; Esteban Celis ; Howard Grey, Compositions and methods for eliciting CTL immunity.
Sette, Alessandro; Sidney, John; Southwood, Scott; Vitiello, Maria A.; Livingston, Brian D.; Celis, Esteban; Kubo, Ralph T.; Grey, Howard M.; Chesnut, Robert W., Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions.
Vertesy Lszl (Eppstein/Taunus DEX) Geisen Karl (Frankfurt am Main DEX) Riess Gnther J. (Frankfurt am Main DEX) Sauber Klaus (Bad Soden am Taunus DEX), Insulin derivatives, a process for the preparation thereof, the use thereof, and a pharmaceutical formulation containing.
Bridon, Dominique P.; Ezrin, Alan M.; Milner, Peter G.; Holmes, Darren L.; Thibaudeau, Karen, Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.